Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population
Bojan Zarić, Vladimir Stojšić, Milana Panjković, Dragana Tegeltija, Vanesa Stepanov, Tomi Kovačević, Tatjana Šarčev, Davorin Z. Radosavljevic, Aleksandar Milovančev, Vasilis Adamidis, Paul Zarogoulidis, Wolfgang Hohenforst‐Schmidt, Georgia Trakada, Aggeliki Rapti, Branislav Perin · Journal of Cancer · 2016
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2016
Abstract
Introduction:The incidence of echinoderm microtubule-associated protein-like4-anaplastic lymphoma kinase (EML4-ALK) mutation among surgically treated patients with adenocarcinoma of the lung of the Eastern European ethnicity is underreported.The aim of this trial was the determination of EML4-ALK mutation frequency in investigated population, and the evaluation of correlations between lung adenocarcinoma subtype and clinical characteristics with mutation status.Patients and methods: This was a prospective trial which included 195 patients with adenocarcinoma of the lung who underwent surgical treatment.ALK mutation screening was performed by immunohistochemistry (IHC).IHC scores of 2+ and 3+ were regarded as positive.Confirmatory FISH was performed in all IHC positive and in 2:1 ratio in negative patients.Results: Overall ALK mutation rate established by IHC was 6.2%, while FISH confirmed rate of 5.1%.The FISH confirmed ALK positivity in 7.6% Hungarians, 5.5% Serbians, and 6.6% Slovakians.Acinar subtype of adenocarcinoma of the lung was significantly (p=0.02)related to EML4-ALK positive mutation status.Most of the patients were males (56.9%), smokers (50.8%), or former smokers (28.7%) with acinar (55.4%) or solid (35.9%) adenocarcinoma of the lung.Sensitivity and specificity of IHC were 100% and 98.9% respectively.Conclusions: ALK mutation rate in surgically treated patients with adenocarcinoma of the lung was found to be 6.2% by IHC and 5.1% by FISH.Acinar subtype of the adenocarcinoma of the lung was significantly related to ALK positive mutation.
Key words: adenocarcinoma of the lung
Open the resolved locator · 10.7150/jca.16768
Metadata licence: OpenAlex metadata (CC0)